Yiqun Rao

Title: Yiqun Rao - Innovator in Bispecific Antigen Binding Proteins

Introduction

Yiqun Rao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of bispecific antigen binding proteins. His work focuses on innovative solutions for cancer treatment, showcasing his commitment to advancing medical science.

Latest Patents

Yiqun Rao holds a patent for "Anti-CD19 and anti-CD3 bispecific antigen binding proteins and uses thereof." This invention provides bispecific antigen binding proteins (BSAPs) that specifically bind to CD3 and a tumor antigen, such as CD19. The patent outlines the uses of these BSAPs for the preparation of pharmaceutical compositions, methods of treating cancer, and kits comprising the BSAPs. He has 1 patent to his name, reflecting his innovative contributions to the field.

Career Highlights

Yiqun Rao is currently associated with Itabmed (HK) Limited, where he continues to work on groundbreaking research and development in the biotechnology sector. His role at the company allows him to collaborate with other experts in the field and contribute to the advancement of cancer therapies.

Collaborations

Some of Yiqun Rao's notable coworkers include Zhihua Huang and Wuzhong Shen. Their collaboration fosters a dynamic environment for innovation and research, enhancing the potential for impactful discoveries in the field of cancer treatment.

Conclusion

Yiqun Rao's work in bispecific antigen binding proteins represents a significant advancement in cancer therapy. His innovative spirit and dedication to research continue to inspire progress in the biotechnology industry.